Analysts’ Viewpoint
The global nuclear imaging devices market is poised for substantial growth, driven by key factors shaping its trajectory. The increase in prevalence of chronic diseases, such as cancer and cardiovascular disorders, is a major factor propelling the nuclear imaging devices industry growth.
Technological advancements, particularly in hybrid imaging modalities including SPECT/CT and PET/CT, enhance the diagnostic accuracy and expand the clinical applications of nuclear imaging devices.
Increase in investments in research and development activities are fostering the continuous evolution of imaging technologies, offering lucrative opportunities for market expansion. Furthermore, the rising geriatric population, which is more prone to various diseases requiring nuclear imaging for diagnosis, fuels market statistics.
The adoption of nuclear imaging devices is expected to increase as healthcare infrastructures worldwide continue to modernize.
Nuclear imaging devices play a crucial role in non-invasive imaging, offering valuable insights into physiological functions for a range of medical conditions and aid in early disease detection. Increase in prevalence of chronic diseases, rise in geriatric population, and continuous technological advancements in imaging modalities are key factors propelling the market.
Introduction of hybrid imaging technologies, such as SPECT/CT and PET/CT, has revolutionized diagnostic capabilities, providing enhanced accuracy and expanded clinical applications. Nuclear imaging devices are integral in early disease detection and monitoring, contributing to improved patient outcomes.
With a proactive approach to diagnostic precision, the global nuclear imaging devices market stands at the forefront of medical imaging innovation, offering a promising future for enhanced healthcare diagnostics.
The continual introduction of new radiotracers and tailored biomarkers is broadening the scope of molecular imaging and driving market development.
Pharmaceutical corporations and university research institutions are significantly investing in the development of radiolabeled substances that can better evaluate disease states and therapy responses. For example, radiolabeled tracers tailored for prostate-specific membrane antigen (PSMA) have showed tremendous promise in identifying metastatic prostate cancer with more sensitivity than traditional methods.This has spurred growing demand for hybrid PET/CT scans.
The approval of new tracers for cardiovascular applications, such as 18F-sodium fluoride and 18F-flurpiridaz F 18, is proving useful in imaging vascular inflammation/calcification and stent patency, facilitating risk prediction and intervention planning.
Furthermore, advances in targeted radionuclide treatment are connecting biomarkers such as PSMA and receptors to therapeutic radiotracers, indicating individualized tailored radiation with little side effects. Innovation is driving upgrade cycles and new purchases of improved PET/SPECT/hybrid equipment, thus bolstering the nuclear imaging devices market value.
The nuclear imaging devices market segmentation in terms of product type includes PET devices, SPECT devices, and planar imaging devices. The SPECT devices segment held significant market share in 2022. SPECT devices play a pivotal role in nuclear medicine by providing detailed three-dimensional images of internal organs and tissues, facilitating accurate diagnosis and treatment planning.
SPECT is particularly effective in imaging bone, cardiac, and neurological conditions, offering a comprehensive and functional view of physiological processes. The diagnostic capabilities of SPECT devices contribute to their widespread adoption in oncology, cardiology, and neurology, addressing a spectrum of medical conditions.
The leading position of SPECT devices underscores their critical role in providing clinicians with valuable insights for informed decision-making. As the demand for precise and non-invasive diagnostic solutions continues to grow, SPECT devices maintain their leadership, solidifying their position as a cornerstone in nuclear imaging devices industry growth.
According to the nuclear imaging devices market analysis, the oncology segment is projected to account for dominant share based on application, during the forecast period.
Oncology applications utilize nuclear imaging technologies such as positron emission tomography (PET) and single-photon emission computed tomography (SPECT) to visualize and analyze the metabolic and functional activity of tissues, aiding in the detection and characterization of tumors.
Nuclear imaging devices offer unparalleled precision in oncology, allowing for early and accurate identification of cancerous lesions. PET scans, for instance, can highlight areas with increased metabolic activity, aiding in staging and determining the extent of cancer spread. Additionally, SPECT imaging provides valuable insights into the functional characteristics of tumors.
As per the nuclear imaging devices market report, the hospitals segment is emerging as a robust end-user segment.
Nuclear imaging devices, including positron emission tomography (PET) and single-photon emission computed tomography (SPECT), find extensive use in hospitals for their capability to provide detailed and accurate images of physiological processes, aiding in the diagnosis and monitoring of various medical conditions.
Larger hospitals often have the financial capacity to invest in state-of-the-art medical infrastructure, including advanced imaging technologies. This positions them as key contributors, boosting the nuclear imaging devices market revenue.
According to the latest nuclear imaging devices market forecast, North America dominated the landscape, with the United States leading the region in 2022. The U.S. stands at the forefront of advancements in healthcare technology, boasting a sophisticated healthcare infrastructure and a robust research and development ecosystem.
The high prevalence of chronic diseases, coupled with a proactive approach to adopting innovative medical imaging solutions, positions the U.S. as a key contributor to the regional market's dominance.
A rising geriatric population and increasing incidence of diseases that necessitate advanced diagnostic capabilities further boosts market dynamics. The U.S. healthcare sector's continuous investments in cutting-edge technologies, coupled with favorable reimbursement policies, enable the widespread adoption of nuclear imaging devices.
The global nuclear imaging devices market is consolidated, with the presence of a small number of leading players. Expansion of product portfolio and mergers & acquisitions are the key strategies implemented by leading players.
Koninklijke Philips N.V., GE Healthcare, Siemens Healthineers AG, Canon Medical Systems Corporation, Shimadzu Corporation, MR Solutions, Neusoft Medical Systems Co., Ltd., Mediso Ltd., and MiE GmbH, are the prominent nuclear imaging devices manufacturers.
Each of these players has been profiled in the nuclear imaging devices market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.
| Attribute | Detail |
|---|---|
| Market Size Value in 2022 | US$ 2.6 Bn |
| Market Forecast Value in 2031 | US$ 4.0 Bn |
| Growth Rate (CAGR) | 4.8% |
| Forecast Period | 2023-2031 |
| Historical Data Available for | 2017-2021 |
| Quantitative Units | US$ Bn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon request |
| Pricing | Available upon request |
It was valued at US$ 2.6 Bn in 2022
It is projected to reach more than US$ 4.0 Bn by the end of 2031
The CAGR is anticipated to be 4.8% from 2023 to 2031
Based on product type, the SPECT devices segment accounted for leading share in 2022
North America is anticipated to account for leading share during the forecast period
Neusoft Medical Systems Co., Ltd., Canon Medical Systems Corporation, Shimadzu Corporation, Koninklijke Philips N.V., GE Healthcare, and Siemens Healthineers AG.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Nuclear Imaging Devices Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Nuclear Imaging Device Market Analysis and Forecasts, 2017 - 2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Regulatory Scenario
5.2. Technological Advancements
5.3. Key Industry Events
5.4. COVID-19 Pandemic Impact on Industry
6. Global Nuclear Imaging Devices Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product Type, 2017 - 2031
6.3.1. PET Devices
6.3.1.1. Standalone PET
6.3.1.2. PET/CT
6.3.1.3. PET/MRI
6.3.2. SPECT Devices
6.3.2.1. Standalone SPECT
6.3.2.2. SPECT/CT
6.3.2.3. SPECT/MRI
6.3.3. Planar Imaging Devices
6.4. Market Attractiveness Analysis, by Product Type
7. Global Nuclear Imaging Devices Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Application, 2017 - 2031
7.3.1. Oncology
7.3.2. Cardiology
7.3.3. Neurology
7.3.4. Others (Nephrology, Immunology, etc.)
7.4. Market Attractiveness Analysis, by Application
8. Global Nuclear Imaging Devices Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2017 - 2031
8.3.1. Hospitals
8.3.2. Imaging Centers
8.3.3. Academic and Research Centers
8.3.4. Others (Clinics, CROs, etc.)
8.4. Market Attractiveness Analysis, by End-user
9. Global Nuclear Imaging Devices Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2017 - 2031
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Nuclear Imaging Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product Type, 2017 - 2031
10.2.1. PET Devices
10.2.1.1. Standalone PET
10.2.1.2. PET/CT
10.2.1.3. PET/MRI
10.2.2. SPECT Devices
10.2.2.1. Standalone SPECT
10.2.2.2. SPECT/CT
10.2.2.3. SPECT/MRI
10.2.3. Planar Imaging Devices
10.3. Market Value Forecast, by Application, 2017 - 2031
10.3.1. Oncology
10.3.2. Cardiology
10.3.3. Neurology
10.3.4. Others (Nephrology, Immunology, etc.)
10.4. Market Value Forecast, by End-user, 2017 - 2031
10.4.1. Hospitals
10.4.2. Imaging Centers
10.4.3. Academic and Research Centers
10.4.4. Others (Clinics, CROs, etc.)
10.5. Market Value Forecast, by Country, 2017 - 2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product Type
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Nuclear Imaging Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2017 - 2031
11.2.1. PET Devices
11.2.1.1. Standalone PET
11.2.1.2. PET/CT
11.2.1.3. PET/MRI
11.2.2. SPECT Devices
11.2.2.1. Standalone SPECT
11.2.2.2. SPECT/CT
11.2.2.3. SPECT/MRI
11.2.3. Planar Imaging Devices
11.3. Market Value Forecast, by Application, 2017 - 2031
11.3.1. Oncology
11.3.2. Cardiology
11.3.3. Neurology
11.3.4. Others (Nephrology, Immunology, etc.)
11.4. Market Value Forecast, by End-user, 2017 - 2031
11.4.1. Hospitals
11.4.2. Imaging Centers
11.4.3. Academic and Research Centers
11.4.4. Others (Clinics, CROs, etc.)
11.5. Market Value Forecast, by Country/Sub-region, 2017 - 2031
11.5.1. Germany
11.5.2. UK
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product Type
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Nuclear Imaging Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2017 - 2031
12.2.1. PET Devices
12.2.1.1. Standalone PET
12.2.1.2. PET/CT
12.2.1.3. PET/MRI
12.2.2. SPECT Devices
12.2.2.1. Standalone SPECT
12.2.2.2. SPECT/CT
12.2.2.3. SPECT/MRI
12.2.3. Planar Imaging Devices
12.3. Market Value Forecast, by Application, 2017 - 2031
12.3.1. Oncology
12.3.2. Cardiology
12.3.3. Neurology
12.3.4. Others (Nephrology, Immunology, etc.)
12.4. Market Value Forecast, by End-user, 2017 - 2031
12.4.1. Hospitals
12.4.2. Imaging Centers
12.4.3. Academic and Research Centers
12.4.4. Others (Clinics, CROs, etc.)
12.5. Market Value Forecast, by Country/Sub-region, 2017 - 2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product Type
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Nuclear Imaging Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2017 - 2031
13.2.1. PET Devices
13.2.1.1. Standalone PET
13.2.1.2. PET/CT
13.2.1.3. PET/MRI
13.2.2. SPECT Devices
13.2.2.1. Standalone SPECT
13.2.2.2. SPECT/CT
13.2.2.3. SPECT/MRI
13.2.3. Planar Imaging Devices
13.3. Market Value Forecast, by Application, 2017 - 2031
13.3.1. Oncology
13.3.2. Cardiology
13.3.3. Neurology
13.3.4. Others (Nephrology, Immunology, etc.)
13.4. Market Value Forecast, by End-user, 2017 - 2031
13.4.1. Hospitals
13.4.2. Imaging Centers
13.4.3. Academic and Research Centers
13.4.4. Others (Clinics, CROs, etc.)
13.5. Market Value Forecast, by Country/Sub-region, 2017 - 2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product Type
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Nuclear Imaging Devices Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product Type, 2017 - 2031
14.2.1. PET Devices
14.2.1.1. Standalone PET
14.2.1.2. PET/CT
14.2.1.3. PET/MRI
14.2.2. SPECT Devices
14.2.2.1. Standalone SPECT
14.2.2.2. SPECT/CT
14.2.2.3. SPECT/MRI
14.2.3. Planar Imaging Devices
14.3. Market Value Forecast, by Application, 2017 - 2031
14.3.1. Oncology
14.3.2. Cardiology
14.3.3. Neurology
14.3.4. Others (Nephrology, Immunology, etc.)
14.4. Market Value Forecast, by End-user, 2017 - 2031
14.4.1. Hospitals
14.4.2. Imaging Centers
14.4.3. Academic and Research Centers
14.4.4. Others (Clinics, CROs, etc.)
14.5. Market Value Forecast, by Country/Sub-region, 2017 - 2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Product Type
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competition Matrix (By Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2022)
15.3. Company Profiles
15.3.1. Koninklijke Philips N.V.
15.3.1.1. Company Overview
15.3.1.2. Financial Overview
15.3.1.3. Product Portfolio
15.3.1.4. Business Strategies
15.3.1.5. Recent Developments
15.3.2. GE Healthcare
15.3.2.1. Company Overview
15.3.2.2. Financial Overview
15.3.2.3. Product Portfolio
15.3.2.4. Business Strategies
15.3.2.5. Recent Developments
15.3.3. Canon Medical Systems Corporation
15.3.3.1. Company Overview
15.3.3.2. Financial Overview
15.3.3.3. Product Portfolio
15.3.3.4. Business Strategies
15.3.3.5. Recent Developments
15.3.4. Siemens Healthineers AG
15.3.4.1. Company Overview
15.3.4.2. Financial Overview
15.3.4.3. Product Portfolio
15.3.4.4. Business Strategies
15.3.4.5. Recent Developments
15.3.5. Shimadzu Corporation
15.3.5.1. Company Overview
15.3.5.2. Financial Overview
15.3.5.3. Product Portfolio
15.3.5.4. Business Strategies
15.3.5.5. Recent Developments
15.3.6. MR Solutions
15.3.6.1. Company Overview
15.3.6.2. Financial Overview
15.3.6.3. Product Portfolio
15.3.6.4. Business Strategies
15.3.6.5. Recent Developments
15.3.7. Neusoft Medical Systems Co., Ltd.
15.3.7.1. Company Overview
15.3.7.2. Financial Overview
15.3.7.3. Product Portfolio
15.3.7.4. Business Strategies
15.3.7.5. Recent Developments
15.3.8. Mediso Ltd.
15.3.8.1. Company Overview
15.3.8.2. Financial Overview
15.3.8.3. Product Portfolio
15.3.8.4. Business Strategies
15.3.8.5. Recent Developments
15.3.9. MiE GmbH
15.3.9.1. Company Overview
15.3.9.2. Financial Overview
15.3.9.3. Product Portfolio
15.3.9.4. Business Strategies
15.3.9.5. Recent Developments
List of Tables
Table 01: Global Nuclear Imaging Devices Market Value (US$ Mn) Forecast, by Product Type, 2017 - 2031
Table 02: Global Nuclear Imaging Devices Market Value (US$ Mn) Forecast, by PET Devices, 2017 - 2031
Table 03: Global Nuclear Imaging Devices Market Value (US$ Mn) Forecast, by SPECT Devices, 2017 - 2031
Table 04: Global Nuclear Imaging Devices Market Value (US$ Mn) Forecast, by Application, 2017 - 2031
Table 05: Global Nuclear Imaging Devices Market Value (US$ Mn) Forecast, by End-user, 2017 - 2031
Table 06: Global Nuclear Imaging Devices Market Value (US$ Mn) Forecast, by Region, 2017 - 2031
Table 07: North America Nuclear Imaging Devices Market Value (US$ Mn) Forecast, by Product Type, 2017 - 2031
Table 08: North America Nuclear Imaging Devices Market Value (US$ Mn) Forecast, by PET Devices, 2017 - 2031
Table 09: North America Nuclear Imaging Devices Market Value (US$ Mn) Forecast, by SPECT Devices, 2017 - 2031
Table 10: North America Nuclear Imaging Devices Market Value (US$ Mn) Forecast, by Application, 2017 - 2031
Table 11: North America Nuclear Imaging Devices Market Value (US$ Mn) Forecast, by End-user, 2017 - 2031
Table 12: North America Nuclear Imaging Devices Market Value (US$ Mn) Forecast, by Country, 2017 - 2031
Table 13: Europe Nuclear Imaging Devices Market Value (US$ Mn) Forecast, by Product Type, 2017 - 2031
Table 14: Europe Nuclear Imaging Devices Market Value (US$ Mn) Forecast, by PET Devices, 2017 - 2031
Table 15: Europe Nuclear Imaging Devices Market Value (US$ Mn) Forecast, by SPECT Devices, 2017 - 2031
Table 16: Europe Nuclear Imaging Devices Market Value (US$ Mn) Forecast, by Application, 2017 - 2031
Table 17: Europe Nuclear Imaging Devices Market Value (US$ Mn) Forecast, by End-user, 2017 - 2031
Table 18: Europe Nuclear Imaging Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017 - 2031
Table 19: Asia Pacific Nuclear Imaging Devices Market Value (US$ Mn) Forecast, by Product Type, 2017 - 2031
Table 20: Asia Pacific Nuclear Imaging Devices Market Value (US$ Mn) Forecast, by PET Devices, 2017 - 2031
Table 21: Asia Pacific Nuclear Imaging Devices Market Value (US$ Mn) Forecast, by SPECT Devices, 2017 - 2031
Table 22: Asia Pacific Nuclear Imaging Devices Market Value (US$ Mn) Forecast, by Application, 2017 - 2031
Table 23: Asia Pacific Nuclear Imaging Devices Market Value (US$ Mn) Forecast, by End-user, 2017 - 2031
Table 24: Asia Pacific Nuclear Imaging Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017 - 2031
Table 25: Latin America Nuclear Imaging Devices Market Value (US$ Mn) Forecast, by Product Type, 2017 - 2031
Table 26: Latin America Nuclear Imaging Devices Market Value (US$ Mn) Forecast, by PET Devices, 2017 - 2031
Table 27: Latin America Nuclear Imaging Devices Market Value (US$ Mn) Forecast, by SPECT Devices, 2017 - 2031
Table 28: Latin America Nuclear Imaging Devices Market Value (US$ Mn) Forecast, by Application, 2017 - 2031
Table 29: Latin America Nuclear Imaging Devices Market Value (US$ Mn) Forecast, by End-user, 2017 - 2031
Table 30: Latin America Nuclear Imaging Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017 - 2031
Table 31: Middle East & Africa Nuclear Imaging Devices Market Value (US$ Mn) Forecast, by Product Type, 2017 - 2031
Table 32: Middle East & Africa Nuclear Imaging Devices Market Value (US$ Mn) Forecast, by PET Devices, 2017 - 2031
Table 33: Middle East & Africa Nuclear Imaging Devices Market Value (US$ Mn) Forecast, by SPECT Devices, 2017 - 2031
Table 34: Middle East & Africa Nuclear Imaging Devices Market Value (US$ Mn) Forecast, by Application, 2017 - 2031
Table 35: Middle East & Africa Nuclear Imaging Devices Market Value (US$ Mn) Forecast, by End-user, 2017 - 2031
Table 36: Middle East & Africa Nuclear Imaging Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017
List of Figures
Figure 01: Global Nuclear Imaging Devices Market Value (US$ Mn) Forecast, 2017 - 2031
Figure 02: Global Nuclear Imaging Devices Market Value Share Analysis, by Product Type, 2022 - 2031
Figure 03: Global Nuclear Imaging Devices Market Value Share Analysis, by PET Devices, 2022 - 2031
Figure 04: Global Nuclear Imaging Devices Market Value Share Analysis, by Standalone PET, 2022 - 2031
Figure 05: Global Nuclear Imaging Devices Market Value Share Analysis, by PET/CT, 2022 - 2031
Figure 06: Global Nuclear Imaging Devices Market Value Share Analysis, by PET/MRI, 2022 - 2031
Figure 07: Global Nuclear Imaging Devices Market Value Share Analysis, by SPECT Devices, 2022 - 2031
Figure 08: Global Nuclear Imaging Devices Market Value Share Analysis, by Standalone SPECT, 2022 - 2031
Figure 09: Global Nuclear Imaging Devices Market Value Share Analysis, by SPECT/CT, 2022 - 2031
Figure 10: Global Nuclear Imaging Devices Market Value Share Analysis, by SPECT/MRI, 2022 - 2031
Figure 11: Global Nuclear Imaging Devices Market Value Share Analysis, by Planar Imaging Devices, 2022 - 2031
Figure 12: Global Nuclear Imaging Devices Market Attractiveness Analysis, by Product Type, 2023 - 2031
Figure 13: Global Nuclear Imaging Devices Market Value Share Analysis, by Application 2022 - 2031
Figure 14: Global Nuclear Imaging Devices Market Value Share Analysis, by Oncology, 2022 - 2031
Figure 15: Global Nuclear Imaging Devices Market Value Share Analysis, by Cardiology, 2022 - 2031
Figure 16: Global Nuclear Imaging Devices Market Value Share Analysis, by Neurology, 2022 - 2031
Figure 17: Global Nuclear Imaging Devices Market Value Share Analysis, by Others (Nephrology, Immunology, etc.), 2022 - 2031
Figure 18: Global Nuclear Imaging Devices Market Attractiveness Analysis, by Application, 2023 - 2031
Figure 19: Global Nuclear Imaging Devices Market Value Share Analysis, by End-user, 2022 - 2031
Figure 20: Global Nuclear Imaging Devices Market Value Share Analysis, by Hospitals, 2022 - 2031
Figure 21: Global Nuclear Imaging Devices Market Value Share Analysis, by Imaging Centers, 2022 - 2031
Figure 22: Global Nuclear Imaging Devices Market Value Share Analysis, by Academic and Research Centers, 2022 - 2031
Figure 23: Global Nuclear Imaging Devices Market Value Share Analysis, by Others (Clinics, CROs, etc.), 2022 - 2031
Figure 24: Global Nuclear Imaging Devices Market Attractiveness Analysis, by End-user, 2023 - 2031
Figure 25: Global Nuclear Imaging Devices Market Value Share Analysis, by Region, 2022 - 2031
Figure 26: Global Nuclear Imaging Devices Market Attractiveness Analysis, by Region, 2023 - 2031
Figure 27: North America Nuclear Imaging Devices Market Value (US$ Mn) Forecast, 2017 - 2031
Figure 28: North America Nuclear Imaging Devices Market Value Share Analysis, by Product Type, 2022 - 2031
Figure 29: North America Nuclear Imaging Devices Market Attractiveness Analysis, by Product Type, 2023 - 2031
Figure 30: North America Nuclear Imaging Devices Market Value Share Analysis, by Application, 2022 - 2031
Figure 31: North America Nuclear Imaging Devices Market Attractiveness Analysis, by Application, 2023 - 2031
Figure 32: North America Nuclear Imaging Devices Market Value Share Analysis, by End-user, 2022 - 2031
Figure 33: North America Nuclear Imaging Devices Market Attractiveness Analysis, by End-user, 2023 - 2031
Figure 34: North America Nuclear Imaging Devices Market Value Share Analysis, by Country, 2022 - 2031
Figure 35: North America Nuclear Imaging Devices Market Attractiveness Analysis, by Country, 2023 - 2031
Figure 36: Europe Nuclear Imaging Devices Market Value (US$ Mn) Forecast, 2017 - 2031
Figure 37: Europe Nuclear Imaging Devices Market Value Share Analysis, by Product Type, 2022 - 2031
Figure 38: Europe Nuclear Imaging Devices Market Attractiveness Analysis, by Product Type, 2023 - 2031
Figure 39: Europe Nuclear Imaging Devices Market Value Share Analysis, by Application, 2022 - 2031
Figure 40: Europe Nuclear Imaging Devices Market Attractiveness Analysis, by Application, 2023 - 2031
Figure 41: Europe Nuclear Imaging Devices Market Value Share Analysis, by End-user, 2022 - 2031
Figure 42: Europe Nuclear Imaging Devices Market Attractiveness Analysis, by End-user, 2023 - 2031
Figure 43: Europe Nuclear Imaging Devices Market Value Share Analysis, by Country/Sub-region, 2022 - 2031
Figure 44: Europe Nuclear Imaging Devices Market Attractiveness Analysis, by Country/Sub-region, 2023 - 2031
Figure 45: Asia Pacific Nuclear Imaging Devices Market Value (US$ Mn) Forecast, 2017 - 2031
Figure 46: Asia Pacific Nuclear Imaging Devices Market Value Share Analysis, by Product Type, 2022 - 2031
Figure 47: Asia Pacific Nuclear Imaging Devices Market Attractiveness Analysis, by Product Type, 2023 - 2031
Figure 48: Asia Pacific Nuclear Imaging Devices Market Value Share Analysis, by Application 2022 - 2031
Figure 49: Asia Pacific Nuclear Imaging Devices Market Attractiveness Analysis, by Application, 2023 - 2031
Figure 50: Asia Pacific Nuclear Imaging Devices Market Value Share Analysis, by End-user, 2022 - 2031
Figure 51: Asia Pacific Nuclear Imaging Devices Market Attractiveness Analysis, by End-user, 2023 - 2031
Figure 52: Asia Pacific Nuclear Imaging Devices Market Value Share Analysis, by Country/Sub-region, 2022 - 2031
Figure 53: Asia Pacific Nuclear Imaging Devices Market Attractiveness Analysis, by Country/Sub-region, 2023 - 2031
Figure 54: Latin America Nuclear Imaging Devices Market Value (US$ Mn) Forecast, 2017 - 2031
Figure 55: Latin America Nuclear Imaging Devices Market Value Share Analysis, by Product Type, 2022 - 2031
Figure 56: Latin America Nuclear Imaging Devices Market Attractiveness Analysis, by Product Type, 2023 - 2031
Figure 57: Latin America Nuclear Imaging Devices Market Value Share Analysis, by Application, 2022 - 2031
Figure 58: Latin America Nuclear Imaging Devices Market Attractiveness Analysis, by Application, 2023 - 2031
Figure 59: Latin America Nuclear Imaging Devices Market Value Share Analysis, by End-user, 2022 - 2031
Figure 60: Latin America Nuclear Imaging Devices Market Attractiveness Analysis, by End-user, 2023 - 2031
Figure 61: Latin America Nuclear Imaging Devices Market Value Share Analysis, by Country/Sub-region, 2022 - 2031
Figure 62: Latin America Nuclear Imaging Devices Market Attractiveness Analysis, by Country/Sub-region, 2023 - 2031
Figure 63: Middle East & Africa Nuclear Imaging Devices Market Value (US$ Mn) Forecast, 2017 - 2031
Figure 64: Middle East & Africa Nuclear Imaging Devices Market Value Share Analysis, by Product Type, 2022 - 2031
Figure 65: Middle East & Africa Nuclear Imaging Devices Market Attractiveness Analysis, by Product Type, 2023 - 2031
Figure 66: Middle East & Africa Nuclear Imaging Devices Market Value Share Analysis, by Application, 2022 - 2031
Figure 67: Middle East & Africa Nuclear Imaging Devices Market Attractiveness Analysis, by Application, 2023 - 2031
Figure 68: Middle East & Africa Nuclear Imaging Devices Market Value Share Analysis, by End-user, 2022 - 2031
Figure 69: Middle East & Africa Nuclear Imaging Devices Market Attractiveness Analysis, by End-user, 2023 - 2031
Figure 70: Middle East & Africa Nuclear Imaging Devices Market Value Share Analysis, by Country/Sub-region, 2022 - 2031
Figure 71: Middle East & Africa Nuclear Imaging Devices Market Attractiveness Analysis, by Country/Sub-region, 2023 - 2031
Figure 72: Global Nuclear Imaging Devices Market Share Analysis, by Company, 2022
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Nuclear Imaging Devices Market
*86 figures and 60 tables includes